“In the next 12 months, FMCG won’t be a great story till the election cycle starts and money goes back to the rural economy or the governme...

M P Gupta, general manager of Mahima Lifesciences, a Chandigarh-based steroid API maker, said the company was expecting a jump in raw mater...

For once, India's favourite bankroller is not a Wall Street bank, nor a Swiss or a blueblooded British one.

Platforms seem to be the winning PE formula, and everyone is busy creating one or many.

The former ED of Tata Sons is hopeful that India will have specialised investors in the next two decades.

Cipla on Tuesday said it has completed the buyout process of South African pharma firm Cipla Medpro for an aggregate consideration of Rs 2,...

The Supreme Court’s landmark judgment on the Novartis Glivec case — disallowing a patent on minor modifications — has started a global deba...

China should accede to India's demand of opening up its huge IT and pharma sectors to it, an official think tank has suggested, arguing tha...

Blackstone presented Intelenet seven investee companies as clients on a platter, which today account for a quarter of the outsourcer’s annu...

Infosys’ buyout of UK’s Axon, touted as the largest cross-border deal in the IT services space, will propel the Indian major into the next ...

Integrated biotechnology firm Biocon on Wednesday said its subsidiary Syngene has entered into a research partnership with global pharma ma...